Spinifex Pharmaceuticals Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $312M

Spinifex Pharmaceuticals General Information

Description

Developer of a new class of therapeutic for chronic pain management. The company's lead product clinically reduces pain in patients with postherpetic neuralgia, a debilitating condition that can follow shingles, providing patients with treatment for pain relief.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Corporate One
  • Suite G5, 84 Hotham Street
  • Preston, Victoria 3072
  • Australia
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • Corporate One
  • Suite G5, 84 Hotham Street
  • Preston, Victoria 3072
  • Australia

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Spinifex Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 24-Jul-2015 $312M Completed Clinical Trials - Phase 2
3. Later Stage VC (Series C) 11-Apr-2014 Completed Clinical Trials - Phase 2
2. Later Stage VC (Series B) 23-Aug-2011 $19.3M $19.3M Completed Clinical Trials - Phase 1
1. Early Stage VC (Series A) 01-Jun-2005 Completed Startup
To view Spinifex Pharmaceuticals’s complete valuation and funding history, request access »

Spinifex Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a new class of therapeutic for chronic pain management. The company's lead product clinically reduces pain
Drug Discovery
Preston, Australia

New York, NY
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Spinifex Pharmaceuticals Competitors (11)

One of Spinifex Pharmaceuticals’s 11 competitors is Xalud Therapeutics, a Venture Capital-Backed company based in New York, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Xalud Therapeutics Venture Capital-Backed New York, NY
Centrexion Therapeutics Venture Capital-Backed Boston, MA
SCILEX Holding Formerly VC-backed Palo Alto, CA
Rein Therapeutics Formerly VC-backed Austin, TX
Supernus Formerly VC-backed Rockville, MD
You’re viewing 5 of 11 competitors. Get the full list »

Spinifex Pharmaceuticals Patents

Spinifex Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2015003223-A1 Heterocyclic compounds and methods of their use Inactive 08-Jul-2013
AU-2013902513-A0 Method of treatment or prophylaxis Inactive 08-Jul-2013
AU-2012900286-A0 "methods of treatment or prophylaxis" Inactive 25-Jan-2012
WO-2013110134-A1 Heterocyclic compounds and methods for their use Inactive 25-Jan-2012
WO-2013110135-A1 Heterocyclic compounds and methods for their use Inactive 25-Jan-2012 C07D401/04
To view Spinifex Pharmaceuticals’s complete patent history, request access »

Spinifex Pharmaceuticals Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Brandon Capital Venture Capital Minority
Canaan Partners Venture Capital Minority
GBS Venture Partners Venture Capital Minority
Innovation Works Venture Capital Minority
Novo Holdings Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Spinifex Pharmaceuticals FAQs

  • When was Spinifex Pharmaceuticals founded?

    Spinifex Pharmaceuticals was founded in 2005.

  • Where is Spinifex Pharmaceuticals headquartered?

    Spinifex Pharmaceuticals is headquartered in Preston, Australia.

  • What industry is Spinifex Pharmaceuticals in?

    Spinifex Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Spinifex Pharmaceuticals a private or public company?

    Spinifex Pharmaceuticals is a Private company.

  • What is the current valuation of Spinifex Pharmaceuticals?

    The current valuation of Spinifex Pharmaceuticals is .

  • What is Spinifex Pharmaceuticals’s current revenue?

    The current revenue for Spinifex Pharmaceuticals is .

  • How much funding has Spinifex Pharmaceuticals raised over time?

    Spinifex Pharmaceuticals has raised $70M.

  • Who are Spinifex Pharmaceuticals’s investors?

    Brandon Capital, Canaan Partners, GBS Venture Partners, Innovation Works, and Novo Holdings are 5 of 7 investors who have invested in Spinifex Pharmaceuticals.

  • Who are Spinifex Pharmaceuticals’s competitors?

    Xalud Therapeutics, Centrexion Therapeutics, SCILEX Holding, Rein Therapeutics, and Supernus are some of the 11 competitors of Spinifex Pharmaceuticals.

  • When was Spinifex Pharmaceuticals acquired?

    Spinifex Pharmaceuticals was acquired on 24-Jul-2015.

  • Who acquired Spinifex Pharmaceuticals?

    Spinifex Pharmaceuticals was acquired by Novartis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process